Skip to main content

Kewaunee Scientific Corporation

Biological Safety Cabinet Market to Hit $0.36B by 2031, Kewaunee Leads M&A

Biological Safety Cabinet Market to Hit $0.36B by 2031, Kewaunee Leads M&A

Delray Beach, Fla. – September 15, 2026 -- The global biological safety cabinet market is projected to grow from USD 0.26 billion in 2026 to USD 0.36 billion by 2031, a 6.6% CAGR, according to MarketsandMarkets.

Pharma investment and biosafety upgrades drive containment equipment demand

Expansion of drug discovery, biologics, cell and gene therapy, and vaccine development is pushing laboratories to replace aging cabinets with certified, higher-performance containment systems. Rising biosafety requirements for handling infectious agents and hazardous materials are accelerating both new installations and equipment upgrades across clinical, academic, and pharmaceutical labs.

Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Kewaunee Scientific Q1 Sales Fall 6.7% as Backlog Climbs to $169 Million

Statesville, N.C. – – September 15, 2026 -- Kewaunee Scientific Corporation (NASDAQ: KEQU) reported first-quarter fiscal 2027 sales of $66.3 million, down 6.7% from $71.1 million a year earlier, even as order backlog rose to $169.0 million from $165.9 million at the end of April.

Net earnings drop to $1.7 million on lower manufacturing volumes

Pre-tax earnings fell 34.7% to $2.56 million from $3.92 million in the prior-year quarter, while net earnings declined to $1.706 million from $3.093 million. Diluted earnings per share came in at $0.58, down from $1.04. EBITDA for the quarter totaled $4.525 million versus $6.32 million a year ago. Backlog, while up sequentially, remains well below the $205.0 million recorded on July 31, 2025.